Table: Garna Biosciences - 9-MTH group results

Carna Biosciences

07/11/2023 06:30

Nov 7 (Reuters)- 
             Garna Biosciences Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to   
                Sep 30, 2023        Sep 30, 2022       Dec 31, 2023  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            711 mln              1.10             902 mln     
                 (-35.1 pct)         (+72.1 pct)       (-34.9 pct)   
  Operating       loss 1.20         loss 753 mln        loss 1.89    
  Recurring       loss 1.20         loss 735 mln        loss 1.91    
  Net             loss 1.23         loss 795 mln        loss 1.94    
  EPS          loss 73.74 yen      loss 58.56 yen    loss 125.25 yen 
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
  
  NOTE - Garna Biosciences Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T